GLTO Stock Analysis: Buy, Sell, or Hold?
GLTO - Galecto, Inc. Common Stock
$28.69
-0.22 (-0.76%)
▼
5d:
-4.53%
30d:
+26.78%
90d:
+29.5%
BUY
MODERATE Confidence
Analysis Updated: Mar 9, 2026 12:00 AM ET
Earnings: Mar 18, 2026
0d
Get Alerted When GLTO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GLTO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: GLTO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GLTO is currently trading at $28.69, which is considered fair based on recent price action.
Technical Outlook: Technically, GLTO is in a strong uptrend. Immediate support is located at $27.10, while resistance sits at $33.99.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.00 (+11.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GLTO is in a strong uptrend. Immediate support is located at $27.10, while resistance sits at $33.99.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.00 (+11.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
55/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
66.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Trading below Wall St target ($32.00)
Support & Resistance Levels
Support Level
$27.10
Resistance Level
$33.99
Current Trend
Strong Uptrend
Technical data as of
Mar 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-18.39
Wall Street Target
$32.00
(+11.5%)
Share & Embed Analysis
Last updated: June 16, 2026 4:02 PM ET
Data refreshes hourly during market hours. Next update: 5:02 PM
Data refreshes hourly during market hours. Next update: 5:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLTO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Hans T Schambye
SELL
700 shares
2026-01-02
Lori Firmani
SELL
135 shares
2026-01-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$102 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 60 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 61 BUY |
